Abstract
Background
Epidemiologic studies demonstrated higher incidence of thyroid cancer in patients with multinodular goiters compared to the general population. The aim of this study was to evaluate the risk of finding significant thyroid cancer in patients undergoing thyroidectomy for presumed benign disease.
Methods
The records of 273 patients operated for indications other than cancer or indeterminate cytology were reviewed and analyzed.
Results
202 (74 %) patients had a preoperative fine-needle aspiration (FNA) performed. FNA was benign in 96 % of patients and non-diagnostic in 4 %. Malignancy was unexpectedly found in 50 (19 %) patients. Papillary carcinoma constituted 94 % of cancers and 86 % of cancers were incidental microcarcinomas. Only 7 (2.6 %) patients of the entire cohort had tumors greater than 1 cm, of those only 3 had a previous benign FNA (false-negative rate 1.5 %).
Conclusions
The rate of significant thyroid cancer found unexpectedly in resected goiters is extremely low. A negative FNA excludes significant cancer with near certainty.
Similar content being viewed by others
References
Pinchera A, Aghini-Lombardi F, Antonangeli L, Vitti P (1996) Multinodular goiter. Epidemiology and prevention. Ann Ital Chir 67(3):317–325
Derwahl M, Studer H (2001) Nodular goiter and goiter nodules: where iodine deficiency falls short of explaining the facts. Exp Clin Endocrinol Diabetes 109(5):250–260
Tan GH, Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126(3):226–231
Cibas ES, Ali SZ (2009) The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132(5):658–665
Pinchot SN, Al-Wagih H, Schaefer S, Sippel R, Chen H (2009) Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger. Arch Surg 144(7):649–655
Frates MC, Benson CB, Doubilet PM et al (2006) Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 91(9):3411–3417
Horvath E, Majlis S, Rossi R et al (2009) An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 94(5):1748–1751
Ackerman R Surgical pathology, vol 2. 10 (edn). Elsevier
Chen AY, Bernet VJ, Carty SE et al (2014) American Thyroid Association statement on optimal surgical management of goiter. Thyroid 24(2):181–189
Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214
Luo J, McManus C, Chen H, Sippel RS (2012) Are there predictors of malignancy in patients with multinodular goiter? J Surg Res 174(2):207–210
Rago T, Fiore E, Scutari M et al (2010) Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol 162(4):763–770
Bahl M, Sosa JA, Nelson RC, Esclamado RM, Choudhury KR, Hoang JK (2013) Trends in incidentally identified thyroid cancers over a decade: a retrospective analysis of 2,090 surgical patients. World J Surg 38:1312–1317. doi:10.1007/s00268-013-2407-9
Gandolfi PP, Frisina A, Raffa M et al (2004) The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Biomed 75(2):114–117
Smith JJ, Chen X, Schneider DF et al (2013) Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients. J Am Coll Surg 216(4):571–577 (discussion 577–579)
Smith JJ, Chen X, Schneider DF et al (2013) Toxic nodular goiter and cancer: a compelling case for thyroidectomy. Ann Surg Oncol 20(4):1336–1340
Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144(6):980–987 (discussion 987–988)
Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey TJ 3rd (2009) Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 19(5):473–477
Lo CY, Chan WF, Lang BH, Lam KY, Wan KY (2006) Papillary microcarcinoma: is there any difference between clinically overt and occult tumors? World J Surg 30(5):759–766. doi:10.1007/s00268-005-0363-8
Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89(8):3713–3720
Roti E, Rossi R, Trasforini G et al (2006) Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91(6):2171–2178
Mehanna H, Al-Maqbili T, Carter B et al (2014) Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab 99(8):2834–2843
Ito Y, Uruno T, Nakano K et al (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13(4):381–387
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mekel, M., Gilshtein, H., Al-Kurd, A. et al. Negative Fine-Needle Aspiration in Patients with Goiter: Should We Doubt It?. World J Surg 40, 124–128 (2016). https://doi.org/10.1007/s00268-015-3216-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-3216-0